Crossmark

Evaluation of carbon dioxide laser therapy for benign tumors of the eyelid margin

Crossref DOI link: https://doi.org/10.1007/s10103-017-2309-4

Published Online: 2017-09-02

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rentka, Aniko

Grygar, Jan

Nemes, Zoltan

Kemeny-Beke, Adam
License Information

Text and Data Mining valid from 2017-09-02
More Information

Article History

Received: 10 February 2015

Accepted: 9 August 2017

First Online: 2 September 2017

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: No funding was secured for this study.

: The protocol was in full compliance with Good Clinical Practices, the Declaration of Helsinki (1996). This work has never been published or submitted for publication elsewhere. All patients underwent a consenting procedure and were informed of the treatment, the use of local anesthesia, as well as possible risks and benefits of the therapy.

: All patients signed a written informed consent for publication of study results regarding the expected cosmetic result, scar formation, depigmentation, recurrence rate, and possible complications regarding the function of the eye and eyelid, e.g., tearing.